
Vilya is creating a novel class of medicines to treat disease targets inside cells, leveraging its proprietary AI engine to design for drug-like properties and ultimately generate new drug candidates.
-
2022 - Founded
-
2023 - Partnered, Series A
Leadership

David Baker, Ph.D.
Co-Founder

Gaurav Bhardwaj, Ph.D.
Co-Founder
Partners
explore more
More Companies
Assort Health
Assort Health’s voice AI agents work with healthcare providers to automate patient communication, including scheduling, insurance verification, and triage.
Cheiron
Cheiron is building the AI-native operating system for drug development—where biopharma teams execute scientific, clinical, regulatory, and competitive workflows end to end on a unified intelligence layer.
Medra
Medra builds physical AI systems to collect life science data with a level of precision and scale humans alone could never achieve.
Nourish
Nourish is the country’s largest dietitian-led metabolic health clinic, building the first AI-native virtual care model to tackle America’s healthcare crisis and reverse chronic disease.
Recursion
Recursion is discovering transformative new treatments by combining automation, machine learning, and the world’s largest biological image datasets.
NASDAQ: RXRX
Squad Health
Squad Health’s AI platform handles all of the administrative work associated with specialty prescriptions, freeing up practitioners to focus on patients.






























